here are some observations, some are subjective some not so...

here are some observations, some are subjective some not so much:


- Brevagen didn't succeed in market, brevagenPlus didnt succeed in market, Genetype for breast cancer is 6 months late and counting, no eta on when it will be released except 'in the coming months' which knowing this company can be 2020 or 2021, and they won't bother explaining why the delays, just a quiet re-forecast in each quarterly, and have the audacity to write 'remains on schedule' after delaying it 6 months. Shows how little they think of shareholder intelligence IMO.

- Also, the test might be getting better, but I don't see a definite market for it. If the test was wanted, Brevagenplus would have been a success. This might be the reason they are trying to enter Chinese market, but no statistical validation for that population (add +12 months for this and more CR / share dilution).

- Shady dumping of a director's entire holding in his own company ($700,000).

- Old board was trying to sell the company, got kicked out by the new mob during a hostile takeover under the guise of promising to align the company with blockchain tech. Gradually this has reduced to ZERO alignment - totally exiting the company vernacular (blockchain not mentioned ONCE in the latest investor presentation or 4C). Again, no explanation to shareholders why, or what's happening with Shivom, blockshine etc. All ventures presumed dead.

- Check the financials. Measly $5,000 incoming cash this quarter, but $789,000 outgoing in salaries alone!!!!!! for ONE quarter!

- CEO is "interim" since 1.5 years, company has promised to find a new CEO replacement, and this hasn't been done. Announcement on 6th Feb, 2018 "In the interim, Dr Kasian has been appointed as acting Chief Executive Office, whilst the Companyundertakes an executive search for a new chief executive officer. " Then, 10 MONTHS later, in November 2018 they announce "The Board has also recently committed to undertake an executive search for a full time CEO. " RECENTLY!?!?! Anyway, here we are, 18 months later and STILL (LOL) one person is both CEO AND Chairman, a recipe for conflict of interest imo.

- One person is COO, CFO and Company secretary.


Good time to sell, before the price tanks even more. Market cap is unbelievably inflated IMO. Soon they will reverse split and the share price will look pretty, and the dilution cycle will begin again.

As usual, all IMO/DYOR/I-could-be-wrong etc etc. Proceed with caution.